Hsp90α在癌症中的发展与治疗的研究进展
Research Progress on the Role of Hsp90α in Cancer Development and Treatment
DOI: 10.12677/acm.2024.1472076, PDF,   
作者: 常思远：青岛大学医学部，山东 青岛；王晓燕：青岛市市立医院国际门诊，山东 青岛；熊 涛：山东第二医科大学临床医学院，山东 潍坊；史光军*：青岛市市立医院东院肝胆胰外科，山东 青岛
关键词: Hsp90α；癌症；癌症治疗；肿瘤代谢；p53；诊断；Hsp90α； Cancer； Cancer Treatment； Tumor Metabolism； p53； Diagnosis
摘要: Hsp90 (Heat Shock Protein 90)是一种在细胞应激条件下诱导表达的分子伴侣蛋白，在发现其可以作为癌症的诊断手段及治疗靶点后，其研究迎来了井喷式的发展。已有研究表明，Hsp90α不仅与肿瘤细胞的生存、增殖和迁移有关，还参与了肿瘤微环境的调控，其高表达与多种癌症类型的不良预后显著相关。近期的研究表明，p53也与Hsp90α拥有复杂而密切的联系，二者之间的交互作用对肿瘤的发生发展有十分重要的作用。在本综述中，我们将探讨Hsp90α在癌症发生和治疗中的作用，关注其与p53这一关键肿瘤抑制蛋白的相互作用。
Abstract: Hsp90 (Heat Shock Protein 90) is a molecular chaperone induced under cellular stress conditions. Since its discovery as a diagnostic tool and therapeutic target for cancer, research on Hsp90 has experienced explosive growth. Studies have shown that Hsp90α is not only involved in the survival, proliferation, and migration of tumor cells but also in the regulation of the tumor microenvironment. Furthermore, its high expression is significantly associated with poor prognosis in various types of cancer. Recent research indicates that p53 also has a complex and close relationship with Hsp90α, and their interactions play a crucial role in tumorigenesis. In this review, we will explore the role of Hsp90α in cancer development and treatment, focusing on its interactions with p53, a key tumor suppressor protein.
文章引用：常思远, 王晓燕, 熊涛, 史光军. Hsp90α在癌症中的发展与治疗的研究进展[J]. 临床医学进展, 2024, 14(7): 746-755. https://doi.org/10.12677/acm.2024.1472076

参考文献

[1] Albakova, Z., Mangasarova, Y., Albakov, A. and Gorenkova, L. (2022) HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis. Frontiers in Oncology, 12, Article 829520. [Google Scholar] [CrossRef] [PubMed]
[2] Bhatia, S., Diedrich, D., Frieg, B., Ahlert, H., Stein, S., et al. (2018). Targeting HSP90 Dimerization via the C Terminus Is Effective in Imatinib-Resistant CML and Lacks the Heat Shock Response. Blood, 132, 307-320.[CrossRef] [PubMed]
[3] Li, Z.N. and Luo, Y. (2023) HSP90 Inhibitors and Cancer: Prospects for Use in Targeted Therapies (Review). Oncology Reports, 49, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[4] Birbo, B., Madu, E.E., Madu, C.O., Jain, A. and Lu, Y. (2021) Role of Hsp90 in Cancer. International Journal of Molecular Sciences, 22, Article 10317. [Google Scholar] [CrossRef] [PubMed]
[5] Bouchier-Hayes, L., Oberst, A., McStay, G.P., Connell, S., Tait, S.W.G., Dillon, C.P., Flanagan, J.M., Beere, H.M. and Green, D.R. (2009) Characterization of Cytoplasmic Caspase-2 Activation by Induced Proximity. Molecular Cell, 35, 830-840. [Google Scholar] [CrossRef] [PubMed]
[6] Chang, C., Tang, X., Woodley, D.T., Chen, M. and Li, W. (2023) The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep. Cells, 12, Article 277. [Google Scholar] [CrossRef] [PubMed]
[7] Chen, S., Yu, Q. and Zhou, S. (2021) Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers in Oncology, 11, Article 765115. [Google Scholar] [CrossRef] [PubMed]
[8] Chiosis, G., Digwal, C.S., Trepel, J.B. and Neckers, L. (2023) Structural and Functional Complexity of HSP90 in Cellular Homeostasis and Disease. Nature Reviews Molecular Cell Biology, 24, 797-815. [Google Scholar] [CrossRef] [PubMed]
[9] Daunys, S., Matulis, D. and Petrikaitė, V. (2019) Synergistic Activity of Hsp90 Inhibitors and Anticancer Agents in Pancreatic Cancer Cell Cultures. Scientific Reports, 9, Article No. 16177. [Google Scholar] [CrossRef] [PubMed]
[10] Hagn, F., Lagleder, S., Retzlaff, M., Rohrberg, J., Demmer, O., Richter, K., Buchner, J. and Kessler, H. (2010) Structural Analysis of the Interaction Between Hsp90 and the Tumor Suppressor Protein P53. Nature Structural and Molecular Biology, 18, 1086-1093. [Google Scholar] [CrossRef] [PubMed]
[11] Han, Y., Zhang, Y., Cui, L., Li, Z., Feng, H., Zhang, Y., Sun, D. and Ren, L. (2021) Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: In Patients with Different Clinicopathologic Characteristics. World Journal of Surgical Oncology, 19, Article No. 228. [Google Scholar] [CrossRef] [PubMed]
[12] Li, W., Sahu, D. and Tsen, F. (2012) Secreted Heat Shock Protein-90 (Hsp90) in Wound Healing and Cancer. Biochimica Et Biophysica Acta-Molecular Cell Research, 1823, 730-741. [Google Scholar] [CrossRef] [PubMed]
[13] Hoter, A., El-Sabban, M.E. and Naim, H.Y. (2018) The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease. International Journal of Molecular Sciences, 19, Article 2560. [Google Scholar] [CrossRef] [PubMed]
[14] Hou, Q., Chen, S., An, Q., Li, B., Fu, Y. and Luo, Y. (2021) Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer. International Journal of Molecular Sciences, 22, Article 7747. [Google Scholar] [CrossRef] [PubMed]
[15] Jhaveri, K., Taldone, T., Modi, S. and Chiosis, G. (2012) Advances in the Clinical Development of Heat Shock Protein 90 (Hsp90) Inhibitors in Cancers. Biochimica et Biophysica Acta-Molecular Cell Research, 1823, 742-755. [Google Scholar] [CrossRef] [PubMed]
[16] Kim, J.Y., Cho, T.M., Park, J.M., Park, S., Park, M., et al. (2022). A Novel HSP90 Inhibitor SL-145 Suppresses Metastatic Triple-Negative Breast Cancer Without Triggering the Heat Shock Response. Oncogene, 41, 3289-3297.[CrossRef] [PubMed]
[17] Li, X., Tong, X., Liu, B., Li, Z., Ding, J., Li, J., Zheng, M., Tian, Y., Yan, S., Huang, M. and Ge, J. (2021) Potential Predictive Value of Plasma Heat Shock Protein 90α in Lung Cancer. Journal of International Medical Research, 49, 1-9. [Google Scholar] [CrossRef] [PubMed]
[18] Liang, X.Q., Li, K-Z., Li, Z., Xie, M.-Z., Tang, Y.-P., et al. (2021). Diagnostic and Prognostic Value of Plasma Heat Shock Protein 90alpha in Gastric Cancer. International Immunopharmacology, 90, Article 107145.[CrossRef] [PubMed]
[19] Liu, L., Deng, Y., Zheng, Z., Deng, Z., Zhang, J., Li, J., Liang, M., Zhou, X., Tan, W., Yang, H., Neckers, L. M., Zou, F. and Chen, X. (2021) Hsp90 Inhibitor STA9090 Sensitizes Hepatocellular Carcinoma to Hyperthermia-Induced DNA Damage by Suppressing DNA-PKcs Protein Stability and MRNA Transcription. Molecular Cancer Therapeutics, 20, 1880-1892. [Google Scholar] [CrossRef] 
[20] Mishra, S.J., Khandelwal, A., Banerjee, M., Balch, M., Peng, S., Davis, R.E., Merfeld, T., Munthali, V., Deng, J., Matts, R.L. and Blagg, B.S.J. (2021) Selective Inhibition of the Hsp90α Isoform. Angewandte Chemie International Edition, 60, 10547-10551. [Google Scholar] [CrossRef] [PubMed]
[21] Boysen, M., Kityk, R. and Mayer, M.P. (2019) Hsp70-and Hsp90-Mediated Regulation of the Conformation of P53 DNA Binding Domain and P53 Cancer Variants. Molecular Cell, 74, 831-843.E4. [Google Scholar] [CrossRef] [PubMed]
[22] Müller, L., Schaupp, A., Walerych, D., Wegele, H. and Buchner, J. (2004) Hsp90 Regulates the Activity of Wild Type P53 under Physiological and Elevated Temperatures. Journal of Biological Chemistry, 279, 48846-48854. [Google Scholar] [CrossRef] 
[23] Nakanishi, M., Morita, Y., Hata, K. and Muragaki, Y. (2016) Acidic Microenvironments Induce Lymphangiogenesis and IL-8 Production via TRPV1 Activation in Human Lymphatic Endothelial Cells. Experimental Cell Research, 345, 180-189. [Google Scholar] [CrossRef] [PubMed]
[24] Neckers, L. and Workman, P. (2012) Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? Clinical Cancer Research, 18, 64-76. [Google Scholar] [CrossRef] 
[25] Park, H.K., Yoon, N.G., Lee, J.E., Hu, S., Yoon, S., Kim, S.Y., Hong, J.H., Nam, D., Chae, Y.C., Park, J.B. and Kang, B.H. (2020) Unleashing the Full Potential of Hsp90 Inhibitors as Cancer Therapeutics through Simultaneous Inactivation of Hsp90, Grp94, and TRAP1. Experimental and Molecular Medicine, 52, 79-91. [Google Scholar] [CrossRef] [PubMed]
[26] Shi, Y., Liu, X., Lou, J., Han, X., Zhang, L., Wang, Q., Li, B., Dong, M. and Zhang, Y. (2014) Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses. Clinical Cancer Research, 20, 6016-6022.
[27] Somogyvári, M., Khatatneh, S. and Sőti, C. (2022) Hsp90: From Cellular to Organismal Proteostasis. Cells, 11, Article 2479. [Google Scholar] [CrossRef] [PubMed]
[28] Taipale, M., Jarosz, D.F. and Lindquist, S. (2010) HSP90 at the Hub of Protein Homeostasis: Emerging Mechanistic Insights. Nature Reviews Molecular Cell Biology, 11, 515-528. [Google Scholar] [CrossRef] [PubMed]
[29] Vogt, M., Dienstbier, N., Schliehe-Diecks, J., Scharov, K., Tu, J.W., et al. (2023) Co-Targeting HSP90 Alpha and CDK7 Overcomes Resistance Against HSP90 Inhibitors in BCR-ABL1+ Leukemia Cells. Cell Death and Disease, 14, Article No. 799. [Google Scholar] [CrossRef] [PubMed]
[30] Wei, W., Liu, M., Ning, S., Wei, J., Zhong, J., Li, J., Cai, Z. and Zhang, L. (2020) Diagnostic Value of Plasma HSP90α Levels for Detection of Hepatocellular Carcinoma. BMC Cancer, 20, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[31] Xue, N., Du, T., Lai, F., Jin, J., Ji, M. and Chen, X. (2022) Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer. International Journal of Molecular Sciences, 23, Article 5532. [Google Scholar] [CrossRef] [PubMed]
[32] Yuan, Z., Wang, L. and Chen, C. (2022) Analysis of the Prognostic, Diagnostic and Immunological Role of HSP90α in Malignant Tumors. Frontiers in Oncology, 12, Article 963719. [Google Scholar] [CrossRef] [PubMed]
[33] Yuan, Z., Wang, L., Hong, S., Shi, C. and Yuan, B. (2022) Diagnostic Value of HSP90α and Related Markers in Lung Cancer. Journal of Clinical Laboratory Analysis, 36, e24462. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, S., Wang, C., Ma, B., Xu, M., Xu, S., Liu, J., Tian, Y., Fu, Y. and Luo, Y. (2020) Mutant P53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion. Cell Reports, 32, Article 107879. [Google Scholar] [CrossRef] [PubMed]
[35] Zuehlke, A.D., Beebe, K., Neckers, L. and Prince, T. (2015) Regulation and Function of the Human HSP90AA1 Gene. Gene, 570, 8-16. [Google Scholar] [CrossRef] [PubMed]

为你推荐